Azurity Pharmaceuticals has completed its acquisition of Covis Group S.à r.l.—making Covis a wholly-owned subsidiary of Azurity.

The French luxury-goods company named Demna Gvasalia as the new artistic director of its flagship label Gucci, as the group ...

Discover key insights from Pharming Group's Q4 2024 earnings call. Explore strong revenue growth, RUCONEST & Joenja drivers, and 2025 strategic priorities.

PharmaCord has about 1,100 employees, while Mercalis has about 1,800 with a high percentage of its employees based in the ...

Maxim Group analyst Jason McCarthy maintained a Buy rating on Dogwood Therapeutics (DWTX – Research Report) yesterday. The company’s shares ...

The Company's current CEO, Thomas Kaas Selsø, will resign from his position as CEO of Pharma Equity Group A/S and its subsidiary Reponex Pharmaceuticals A/S with effect from 31 March 2025. The Board ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Egypt - Macro Group Pharmaceutical (Macro Capital) suffered 86.02%% year-on-year (YoY) lower consolidated net losses attributable to the parent company at EGP 38.098 million in 2024, versus EGP ...

One Indian pharmaceutical company dey manufacture unlicensed, highly addictive opioids and dey export dem illegally to West Africa wia dem dey drive a major public health crisis for countries ...

A snapshot of the stocks on the move, featuring Domain Holdings Australia, Guzman y Gomez, Mayne Pharma, Rural Funds Group Domain Holdings Australia (ASX:DHG) has received an unsolicited, non-binding ...

A new executive committee has taken charge at the Pharmaceutical Research and Manufacturers Association Gulf for the period 2025–27. This diverse and accomplished group of industry leaders is ...